Curriculum vitae

Main Research Areas
  • Tumour and infection immunology
  • Epidemiology of infections of  von Infektionen immunosuppressed patients
  • Clinical diagnostic and therapeutical studies
Professional Career
2014 Deputy head of the Nationales Referenzzentrum für invasive Pilzinfektionen
2013 W2-professorship in infection research in haematology and oncology, medical faculty, Friedrich-Schiller University Jena
2010 Habilitation in internal medicine, Rheinische Friedrich-Wilhelms University Bonn
2008-2013 Senior physician in the dept. haematology / oncology (med. clinic III), University Hospital, Bonn
2007-2008 EBMT Fellowship Bone Marrow Transplantation Programme, Leeds, UK
2007 Acceptance of the priority area haematology / oncology
2006 Specialist in internal diseases
2003-2004 Gerok fellowship within the BonFor funding programme, medical faculty Bonn
1999-2007 Doctor in practical training (AiP) /assistant physician in internal medicine, University Hospital Bonn
1999 PhD in clinical pharmacology, „magna cum laude“, medical faculty, Rheinische Friedrich-Wilhelms University Bonn
1998 Staatsexamen (state examination) human medicine
Awards · Appointments · Scientific Activities
Since 2013 Member of the ethics commission, medical faculty of the FSU Jena
Since 2013 Board member of the working group dealing with infections in haematology and oncology (AGIHO) of the Deutsche Gesellschaft für Hämatologie und internistische Onkologie (DGHO)
Since 2008 Member of the AGIHO
2008-2010 Assistant lecturer at the medical clinic III of the University Hospital Bonn
2002-2006 Member of the statutes commission of the medical faculty of the Rheinische Friedrich-Wilhelms University Bonn
2009 Best abstract DGHO
2008 Poster award
Since 2004 Assessor of several magazines

Publications

Böttcher S, Hartung S, Meyer F, Rummler S, Voigt K, Walther G, Hochhaus A, von Lilienfeld-Toal M, Jahreis S (2021) Human mucosal-associated invariant T cells respond to Mucorales species in a MR1-dependent manner. Med Mycol 59(5), 505-509.
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M (2021) Evidence-based management of COVID-19 in cancer patients: Guideline by the infectious diseases working party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur J Cancer 140, 86-104.
Roth M, Holtmann C, Daas L, Kakkassery V, Kurzai O, Geerling G, Bäurle S, Bayoudh W, Brücher V, Cvetkova-Fischer N, Dias Blak M, Bornstein A, Fischer C, Fuest M, Grisanti S, Herwig-Carl M, Kroll S, Lenk J, Lommatzsch C, MacKenzie C, Matthaei M, Mehlan J, Messmer E, Müller V, Pawlik V, Ranjbar M, Renner-Wilde A, Rickmann A, Saeger M, Schargus M, Schwarz L, Seitz B, Steindor F, Unterlauf JD, Viestenz A, von Lilienfeld-Toal M, Walther G (2021) Results from the German fungal keratitis registry: Significant differences between cases with and without a history of contact lens use. Cornea 40(11), 1453-1461.
Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, Isberner N, Köhler P, Lanznaster J, Merle U, Nadalin S, Piepel C, Schneider J, Schons M, Strauss R, Tometten L, Vehreschild JJ, von Lilienfeld-Toal M, Beutel G, Wille K (2021) COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry. Ann Hematol 100(2), 383-393.
Walther G, Zimmermann A, Theuersbacher J, Kaerger K, von Lilienfeld-Toal M, Roth M, Kampik D, Geerling G, Kurzai O (2021) Eye infections caused by filamentous fungi: Spectrum and antifungal susceptibility of the prevailing agents in germany. J Fungi (Basel) 7(7), 511.
Brioli A, Manz K, Pfirrmann M, Hänel M, Schwarzer AC, Prange-Krex G, Fabisch C, Knop S, Illmer T, Krammer-Steiner B, Hochhaus A, von Lilienfeld-Toal M, Mügge LO (2020) Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN). J Cancer Res Clin Oncol 146(3), 749-759.
Crodel CC, Jentsch-Ullrich K, Koschmieder S, Kämpfe D, Griesshammer M, Döhner K, Jost PJ, Wolleschak D, Isfort S, Stegelmann F, Jilg S, Hofmann V, Auteri G, Rachow T, Ernst P, Brioli A, von Lilienfeld-Toal M, Hochhaus A, Palandri F, Heidel FH (2020) Frequency of infections in 948 MPN patients: A prospective multicenter patient-reported pilot study. Leukemia 34(7), 1949-1953.
Mayer K, Hahn-Ast C, Schwab K, Schmidt-Wolf IGH, Brossart P, Glasmacher A, von Lilienfeld-Toal M (2020) Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review. Eur J Haematol 104(6), 538-545. (Review)
Mian H, Grant SJ, Engelhardt M, Pawlyn C, Bringhen S, Zweegman S, Stege CAM, Rosko AE, von Lilienfeld-Toal M, Wildes TM (2020) Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the international forum for optimizing care of older adults with myeloma. J Geriatr Oncol 11(5), 764-768.
Rachow T, Lamik T, Kalkreuth J, Kurze S, Wagner K, Stier P, Hammersen FJ, Rüthrich MM, Winkelmann N, Klink A, Hilgendorf I, Hermann B, Lang S, Hochhaus A, von Lilienfeld-Toal M (2020) Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study. Transpl Infect Dis 22(6), e13415.